Skip to content
Prapela logo — Prapela is a breakthrough noninvasive stimulation therapy th...

Prapela

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns.

Founded 2017 United States Biddeford, United States 4 employees Grant Total: $8.18M Health Care, Health and Wellness +1

General Information

Company Name Prapela
Founded Year 2017
Location United States Biddeford, United States
Employees 4
Industries Health Care, Health and Wellness, Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Prapela. To contact Prapela, visit prapela.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Prapela compare?

A PDF of Prapela and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Prapela soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Prapela

Prapela is a health care startup founded in 2017 and headquartered in the United States. The company has developed a breakthrough noninvasive stimulation therapy aimed at improving breathing and oxygenation in newborns. Leveraging the science of Stochastic Resonance, Prapela's therapy has shown promise in enhancing breathing rhythm and lung function in newborns. Notably, since 2017, Prapela has secured over $8M in awards and grants for the clinical evaluation of its therapy, particularly in the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. The last investment in December 2023 came in the form of a grant investment from the Charles Hood Foundation. Moving forward, Prapela aims to further enhance its therapy to treat conditions such as preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, visit prapela.com.

Business keywords: noninvasive stimulation therapy, newborn health, pediatric medical device, neonatology, apnea of prematurity, neonatal abstinence syndrome, intermittent hypoxemia, infant sleep, respiratory syncytial virus, medical device startup, neonatal intensive care, oxygenation, babies health, grants funding, FDA collaboration

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Charles Hood Foundation
19 Dec 2023
Grant $3.50M 1
National Institutes of Health
10 Mar 2023
Grant $2.50M 1
National Institutes of Health
20 May 2021
Grant $100.00K 1
Maine Technology Institute
20 Apr 2021
Non Equity Assistance $27.00K 1
U.S. Small Business Administration
11 Nov 2020
Non Equity Assistance $100.00K 1
Southern Maine Planning and Development Commission
15 Oct 2020
Grant $200.00K 1
Massachusetts Life Sciences Center
03 Sep 2019
Grant $1.00M 1
Ohio Third Frontier
27 Aug 2019
Grant $222.00K 1
National Institute on Drug Abuse (NIDA)
19 Mar 2019
Venture Round Undisclosed 1
Springhood
20 Oct 2018

View All 15 Funding Rounds

Prapela Alternatives & Competitors

View All Alternatives
Prapela vs
Bilihome
Bilihome The Netherlands

wearable jaundice therapy for natural newborn care

Seed
8 employees
Care Economy, Fashion
Prapela vs

Heamac is a design-driven Company which is on a mission to provide the best products for all.

Non Equity Assistance
5 employees
Health Care, Health and Wellness
Prapela vs

Charitable, Multi-Specialty Hospital

560 employees
Analytics, Health Care

FAQ About Prapela

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns.
Prapela was founded in 2017.
Prapela is headquartered in Biddeford, United States.
Prapela operates in Health Care, Health and Wellness and Life Sciences. Its work centres on noninvasive stimulation therapy, newborn health, pediatric medical device and neonatology.
Prapela has approximately 4 employees.
Prapela has completed 15 funding rounds, raising a total of $8.18M. The latest funding stage is Grant.
Top alternatives and competitors to Prapela include Bilihome, Heamac Healthcare Pvt Ltd, Deenanath Mangeshkar Hospital and Research Center, Grupo Perinatal, Arsanis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prapela and Bilihome are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Prapela, https://bouncewatch.com/company/prapela, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout